PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of peerjLatest ArticlesFor AuthorsEditorial BoardPeerJPeerJ
 
PeerJ. 2017; 5: e3047.
Published online 2017 February 28. doi:  10.7717/peerj.3047
PMCID: PMC5333547

Genomic analysis of ST88 community-acquired methicillin resistant Staphylococcus aureus in Ghana

Academic Editor: Elisabeth Grohmann

Abstract

Background

The emergence and evolution of community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA) strains in Africa is poorly understood. However, one particular MRSA lineage called ST88, appears to be rapidly establishing itself as an “African” CA-MRSA clone. In this study, we employed whole genome sequencing to provide more information on the genetic background of ST88 CA-MRSA isolates from Ghana and to describe in detail ST88 CA-MRSA isolates in comparison with other MRSA lineages worldwide.

Methods

We first established a complete ST88 reference genome (AUS0325) using PacBio SMRT sequencing. We then used comparative genomics to assess relatedness among 17 ST88 CA-MRSA isolates recovered from patients attending Buruli ulcer treatment centres in Ghana, three non-African ST88s and 15 other MRSA lineages.

Results

We show that Ghanaian ST88 forms a discrete MRSA lineage (harbouring SCCmec-IV [2B]). Gene content analysis identified five distinct genomic regions enriched among ST88 isolates compared with the other S. aureus lineages. The Ghanaian ST88 isolates had only 658 core genome SNPs and there was no correlation between phylogeny and geography, suggesting the recent spread of this clone. The lineage was also resistant to multiple classes of antibiotics including β-lactams, tetracycline and chloramphenicol.

Discussion

This study reveals that S. aureus ST88-IV is a recently emerging and rapidly spreading CA-MRSA clone in Ghana. The study highlights the capacity of small snapshot genomic studies to provide actionable public health information in resource limited settings. To our knowledge this is the first genomic assessment of the ST88 CA-MRSA clone.

Keywords: Staphylococcus aureus, Whole genome sequencing, MRSA, ST88, Comparative genomics, Phylogeography, CA-MRSA

Introduction

Since the 1990s, community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections have been increasing worldwide (Centers for Disease Control and Prevention, 2013; de Kraker et al., 2011). CA-MRSA clones are known to be more virulent than hospital-acquired MRSA, with infections linked to significant mortality and morbidity (Chambers, 2001; Chua et al., 2011, 2014; Etienne, 2005; Kourbatova et al., 2005; Seybold et al., 2006). First reported in Australia and the United States, CA-MRSA occurrence has been increasing, with epidemics due to clones such as ST8 USA300 in the United States (Diekema et al., 2014), ST93 and ST1 in Australia (Coombs et al., 2009), ST80 in Europe (Otter & French, 2010), ST59 in China and Taiwan (Chen & Huang, 2014), ST772 in India (D’Souza, Rodrigues & Mehta, 2010; DeLeo et al., 2010; Nadig et al., 2012; Shambat et al., 2012) and ST72 in South Korea (Kim et al., 2007). Other identified CA-MRSA clones belong to ST30 (South West Pacific clone) (Williamson, Coombs & Nimmo, 2014), ST45 (Berlin clone) (Witte et al., 1997), ST1 (USA400) (DeLeo et al., 2010) and ST78 (Western Australian MRSA-2) (Williamson, Coombs & Nimmo, 2014). In Africa, the distribution of MRSA clones in general is not well understood (Abdulgader et al., 2015). A recent review on MRSA in Africa with data from 15 of the 54 countries identified community clones of ST8-IV [2B] (USA300) and ST88-IV [2B] “West Australia MRSA-2 clone” in both community and health care associated infections in seven countries and a “Brazilian/Hungarian clone” ST239-III [3A] in hospital acquired infections in nine countries (Abdulgader et al., 2015). The European ST80-IV [2B] clone was limited to Algeria, Egypt and Tunisia while clonal types ST22-IV [2B], ST36-II [2A] and ST612-IV [2B] have only been reported so far in South Africa (Abdulgader et al., 2015). Among the two CA-MRSA clones, the ST8IV [2B] clone is an internationally disseminated clone recognized in every continent except Antarctica (David & Daum, 2010). The ST88-IV [2B] CA-MRSA clone however is predominant in Sub-Saharan Africa (West, Central and East Africa) with reported rates of 24.2–83.3% of all MRSA isolates (Schaumburg et al., 2014). Studies from Angola (Conceição et al., 2014), Cameroon (Breurec et al., 2011), Gabon (Ngoa et al., 2012; Schaumburg et al., 2011), Ghana (Amissah et al., 2015; Egyir et al., 2013, 2014), Madagascar (Breurec et al., 2011), Niger (Breurec et al., 2011), Nigeria (Ghebremedhin et al., 2009; Raji et al., 2013; Shittu et al., 2012) and Senegal (Breurec et al., 2011) have identified it as a major circulating clone within both hospital and community settings. It was also detected in children from West Africa who underwent surgery in Switzerland but had been hospitalized in their home countries prior to surgical treatment (Blanc et al., 2007). Globally, this clone has been identified in China (Yu et al., 2008) and Japan (Maeda et al., 2012) in lower proportion (5.3–12.5%) than in Africa and sporadically in Belgium (Denis et al., 2005), Portugal (Aires-de-Sousa et al., 2008) and Sweden (Fang et al., 2008).

Control of MRSA infections is assisted by a thorough knowledge of the epidemiology and dissemination of specific clones. To this end, we employed whole genome sequencing and comparative genomics to describe in detail ST88 CA-MRSA isolates in comparison to other MRSA lineages worldwide.

Materials and Methods

Bacterial isolates and antibiogram analysis

The 17 ST88 S. aureus isolates analysed from Ghana are listed in Table 1 and comprised five strains isolated in the Akwapim South District (Eastern Region) of Ghana with previously published genome data (GenBank accession numbers: LFNJ00000000, LFNI00000000, LFNH00000000, LFMH00000000, LFMG00000000) (Amissah et al., 2015) and 12 isolates recovered from wounds of 11 patients attending Buruli ulcer (BU) treatment centres in the Ga-South and Ga-West municipalities (Greater Accra Region) of Ghana with two isolates from one patient; one a PVL positive isolate and the other PVL negative. Patients were outpatients, nine of whom had laboratory confirmed BU. Initial isolate identification was made using colony and microscopic morphology, catalase and coagulase biochemical reactions and a Staphylase kit BD BBL™ Staphyloslide Latex Test (Becton, Dickinson and Company, NJ, USA) for further confirmation. Antibiograms were determined using the Kirby Bauer disc diffusion method according to CLSI guidelines (CLSI, 2014) and PCR targeting the mecA gene (Oliveira & de Lencastre, 2002) for identification of MRSA. Ethical clearance was obtained from the institutional review board of the Noguchi Memorial Institute for Medical Research (NMIMR) (Federal-wide Assurance number FWA00001824). All study participants were well informed of the study objectives and written informed consent was obtained either from the patient or from the guardian of the patient.

Table 1
S. aureus ST88 isolates tested in this study.

DNA extraction, whole genome sequencing and analysis

Genomic DNA was extracted from isolates using the Qiagen DNeasy kit and protocol (Qiagen, Hilden, Germany). DNA libraries were prepared using Nextera XT (Illumina, San Diego, CA, USA) and whole genome sequencing was performed using the Illumina MiSeq with 2 × 300 bp chemistry. Small Molecular Real Time sequencing was performed on the RS-II (Pacific Biosciences, California, United States) using P6-C4 chemistry, and reference genome assembly was performed as described (Baines et al., 2016).

Read mapping, variant calling and phylogenomic analysis

The sequence reads were processed using Nullarbor (nullarbor.pl 0.6, https://github.com/tseemann/nullarbor), a recently developed bioinformatics pipeline for public health microbial genomics as described previously (Kwong et al., 2016). S. aureus ST88 raw sequence reads with accession numbers ERS1354589-600 have been deposited in the European Nucleotide Archive (ENA), Project PRJEB15428. Ortholog clustering was performed using Roary (Page et al., 2015) and was visualized with Fripan (http://drpowell.github.io/FriPan/). Recombination within the core genome was inferred using ClonalFrameML v1.7 (Didelot & Wilson, 2015) with the whole genome alignment generated by Nullarbor. Using FastTree v2.1.8 (Price, Dehal & Arkin, 2010), a ML tree was generated and used as a guide tree for ClonalFrameML. Positions in the reference genome that were not present in at least one genome (non-core) were omitted from the analysis using the “ignore_incomplete_sitestrue” option and providing ClonalFrameML with a list of all non-core positions. Maximum likelihood trees were constructed using a recombination free SNP alignment using FastTree. Bootstrap support was derived from comparisons between the original trees against 1,000 trees that were built upon pseudo-alignments (sampled from the original alignment with replacement).

Results and Discussion

ST88 complete reference genome

A prerequisite for high-resolution comparative genomics by read-mapping is a high-quality, complete reference genome, closely related to the bacterial population under investigation (Kwong et al., 2016). There were no fully assembled ST88 S. aureus genomes publicly available.

Hence, to address this issue, we selected the methicillin-susceptible, penicillin-resistant ST88 S. aureus isolate AUS0325. This clinical isolate was obtained in 2013 from a patient in Melbourne, Australia who had a persistent infection of a prosthetic joint, and was part of a separate, unpublished study. The AUS0325 genome comprised a 2,771,577 bp circular chromosome with 32.9% GC content. There were no plasmids; the beta-lactamase operon (bla) was carried by the Tn552 transposon and integrated into the chromosome. The overall chromosome architecture of AUS0325 was like representative S. aureus genomes from other community-associated lineages (ST1, ST8 and ST93) but with five distinct regions of difference, discussed in more detail below (Fig. 1A). We took advantage of the PacBio data to define the Sa_aus0325 methylome. Motif analysis and inspection of the AUS0325 annotation identified two active type I restriction modification hsdMS loci. Protein alignment of the two hsdS alleles with previously characterised hsdS proteins allowed the attribution of target recognition sequences to either allele (Monk et al., 2015) (Table 2). The first hsdS recognized a motif not previously described, while the second hsdS contained an identical sequence to the target recognition domain-2 of CC30-2 and ST93-2, which recognises TCG (Table 2).

Figure 1
Comparative genomic analysis of S. aureus ST88.
Table 2
Sa_aus0325 methylome analysis.

ST88 population structure

To understand the genomic diversity and evolutionary origin of the ST88 isolates, a core genome phylogeny was inferred by mapping reads from the 17 ST88 isolates (Table 1; Fig. 1B), two published ST88 MRSA genomes from Lebanon and USA and 15 other geographically and genetically distinct S. aureus clones to AUS0325 (Table 3; Fig. 1B). To assess the clonal ancestry, SNPs within inferred regions of recombination (71,862 clonal SNPs; 26,570 recombinogenic SNPs) (Fig. S1) were removed and a maximum likelihood phylogenomic tree was established using the clonal core SNP alignment (71,862 SNPs). All 20 ST88 genomes formed a discrete, closely related lineage, defined by only 1,759 core genome SNPs, compared with 71,862 SNPs among all 35 S. aureus genomes (Figs. 1B and and2A).2A). The global tree was rooted using Bacillus_subtilis_B4068 (GenBank ID: JXHK00000000) (Berendsen et al., 2016) as an out-group and this phylogeny indicated ST88 shares a most recent common ancestor (MRCA) with ST72 (Fig. 1A).

Table 3
Comparator reference genomes.
Figure 2
High resolution ST88 phylogeny and accessory genome analysis.

Five distinct genomic regions were identified by ortholog comparisons, enriched among the ST88 genomes compared to the 15 other diverse S. aureus genomes. These regions included νSAα (GI-3, Fig. 1) that harboured 10 staphylococcal superantigen-like (ssl) genes, of which four were uniquely present in the ST88 isolates. Upregulation of SSLs has been reported in some CA-MRSA strains and may be involved in neutrophil and complement activation (Foster, 2005; Voyich et al., 2005). GI-3 also harboured the first of the two functional type I restriction modification hsdMS loci (see above, Table 2). GI-1 and GI-4 may be mobile integrative elements of unknown function with the presence of putative integrases and 4 and 12 CDS, respectively, all encoding hypothetical proteins. GI-1 also harbours elements of a putative restriction modification system (Fig. 1; Table S1). GI-2 contains 13 CDS. Most of unknown function although three CDS may encode membrane proteins (Fig. 1; Table S1). GI-5 had 14 CDS that included the second of the type I restriction modification hsdMS loci and seven CDS encoding putative proteases (Table 2; Table S1).

Evolution and molecular epidemiology of ST88 in Ghana

To assess the evolutionary relationships among the ST88 genomes, a phylogenomic tree comprised exclusively of ST88 genomes was established using clonal, core SNPs (1,759 clonal SNPs; 207 recombinogenic SNPs) (Fig. S2; Fig. 2A). The tree was rooted using an ST93 genome (Sa_JKD6159) as an out-group. The phylogeny and the restricted genomic diversity (658 core SNPs) suggests that the spread of ST88 MRSA in Ghana is a recent phenomenon, with isolates from the United States, Australia and Lebanon ancestral to the spread of these isolates in Ghana. Five specific clusters of CDS were also found to be exclusively present with the African ST88 genomes (Fig. 2C). These CDS were different to the five genomic regions identified in all ST88 relative to other S. aureus clones (Fig. 1B) suggesting that they were horizontally acquired by an ST88 MRCA that has since spread in Ghana (although a significantly larger sampling effort would be required to confirm this hypothesis). These regions harbour CDS suggestive of plasmid, phage and other mobile DNA elements (Table S2). We conducted a phylogeographic analysis to formally assess the relationship between the Ghanaian ST88 phylogeny and the specific geographic origin of the isolates, based on patient villages. However, there was no correlation between geography and phylogeny, suggesting again that the spread of ST88 in Ghana has been recent and rapid (Fig. 3).

Figure 3
Relationship between phylogeny of Ghanaian ST88 and their geographic origin.

Phenotypic and genotypic antibiotic resistance

All 17 Ghanaian ST88 isolates harboured a SCCmec-IV [2B] cassette, and displayed phenotypic resistance to β-lactams, tetracycline and chloramphenicol (Table 1). Isolates were variably resistant to erythromycin, clindamycin, trimethoprim, amikacin and streptomycin (Table 1). There was agreement between phenotypic and inferred genotypic resistance (Fig. 1B). For the four genes (blaZ, mecA, tetL and tetM) detected in all 12 ST88 isolates from the Greater Accra Region, resistance correlated with phenotypic resistance to all β-lactams and tetracyclines. Six isolates showed phenotypic and genotypic resistance to chloramphenicol (Table 1; Fig. 1B). Five of these isolates were from the same health centre; however, the time of isolation and the geographic origins of the patients were different, suggesting that these isolates are widespread across the region and were not acquired from a common source.

Conclusion

The analysis presented here suggests that S. aureus ST88-IV is an emerging CA-MRSA clone in Ghana. This has the potential to become a serious public health threat, with implications for the treatment of S. aureus infections in Ghana, where there is no developed surveillance infrastructure to monitor antibiotic resistance. The abuse and misuse of antibiotics by health care givers and patients in Ghana are extensive (Kpeli et al., 2016). The development of resistance is furthermore encouraged by the widespread availability of higher classes of antibiotics to lower level health centres from regional medical stores, in addition to the unrestricted sale of these medicines to over-the-counter medicine sellers by pharmaceutical wholesalers, even though existing laws are supposed to limit the scope of these facilities to handle such medicines. Also implicated and widely documented are the prescribing practices of clinicians; with over-reliance on presumptive treatment and haphazardly prescribing antibiotics without recourse to due laboratory investigation. CA-MRSA has undergone rapid evolution and expansion worldwide. Because of its epidemic potential and limited treatment options, vigilance and antibiotic stewardship programmes need to be put in place to prevent further spread.

Supplemental Information

10.7717/peerj.3047/supp-1

Supplemental Information 1

Recombination analysis among the 20 ST88 and 15 non-ST88 genomes.

Light grey and black blocks denote recombination regions detected in ancestral nodes and the sampled genomes, respectively. In total there were 98,432 core SNPs, 26,570 of which were located within inferred regions of recombination. Red coloured isolates ST88, black; non-ST88 isolates.

10.7717/peerj.3047/supp-2

Supplemental Information 2

Recombination analysis among the 20 ST88 genomes.

Light grey and black blocks denote recombination regions detected in ancestral nodes and the sampled genomes, respectively. In total there were 1,966 core SNPs, 207 of which were located within inferred regions of recombination. Blue and red coloured isolates from the Greater Accra and Eastern Region of Ghana respectively. Pink coloured isolate from the United States, Green from Melbourne and Black from Lebanon.

10.7717/peerj.3047/supp-3

Supplemental Information 3

Genomic regions enriched in S. aureus MRSA ST88.
10.7717/peerj.3047/supp-4

Supplemental Information 4

Genome regions enriched in S. aureus MRSA ST88 from Ghana.

Acknowledgments

We are grateful to the healthcare workers and patients at the Ga West and Ga South Municipalities and to Miss Nana Ama Amissah for giving us access to genome data.

Funding Statement

This work was supported by the Stop Buruli initiative of the UBS Optimus foundation and the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

The following grant information was disclosed by the authors:

Stop Buruli initiative of the UBS Optimus foundation and the Volkswagen Foundation .

Additional Information and Declarations

Competing Interests

Timothy Stinear is an Academic Editor for PeerJ.

Author Contributions

Grace Kpeli conceived and designed the experiments, performed the experiments, analyzed the data, wrote the paper, prepared figures and/or tables and reviewed drafts of the paper.

Andrew H. Buultjens conceived and designed the experiments, performed the experiments, analyzed the data, wrote the paper, prepared figures and/or tables and reviewed drafts of the paper.

Stefano Giulieri performed the experiments, analyzed the data, contributed reagents/materials/analysis tools, wrote the paper and reviewed drafts of the paper.

Evelyn Owusu-Mireku performed the experiments, reviewed drafts of the paper.

Samuel Y. Aboagye performed the experiments, reviewed drafts of the paper.

Sarah L. Baines analyzed the data, reviewed drafts of the paper.

Torsten Seemann analyzed the data, contributed reagents/materials/analysis tools and reviewed drafts of the paper.

Dieter Bulach analyzed the data, contributed reagents/materials/analysis tools and reviewed drafts of the paper.

Anders Gonçalves da Silva contributed reagents/materials/analysis tools and reviewed drafts of the paper.

Ian R. Monk analyzed the data, wrote the paper and reviewed drafts of the paper.

Benjamin P. Howden reviewed drafts of the paper.

Gerd Pluschke contributed reagents/materials/analysis tools and reviewed drafts of the paper.

Dorothy Yeboah-Manu conceived and designed the experiments, contributed reagents/materials/analysis tools and reviewed drafts of the paper, supervision.

Timothy Stinear conceived and designed the experiments, performed the experiments, analyzed the data, contributed reagents/materials/analysis tools, wrote the paper, prepared figures and/or tables and reviewed drafts of the paper, supervision.

Ethics

The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers):

Ethical clearance was obtained from the institutional review board of the Noguchi Memorial Institute for Medical Research (NMIMR) (Federal-wide Assurance number FWA00001824). All study participants were well informed of the study objectives and written informed consent was obtained either from the patient or from the guardian of the patient.

DNA Deposition

The following information was supplied regarding the deposition of DNA sequences:

  1. The S. aureus ST88 raw sequence reads are accessible via ENA, Project PRJEB15428 (http://www.ebi.ac.uk/ena/data/view/PRJEB15428).
  2. The AUS0325 Chromosome Assembly is accessible via ENA, LT615218 (http://www.ebi.ac.uk/ena/data/view/LT615218).
  3. The AUS0325 PacBio raw sequence reads is accessible via ENA, ERS1354601 (http://www.ebi.ac.uk/ena/data/view/ERS1354601).
  4. The MiSeq Data (Raw) for SA_NOG sequences described here are accessible via GenBank accession numbers: ERR1638070 to ERR1638081.

Data Deposition

The following information was supplied regarding data availability:

Strain data protocol has been deposited in Figshare: DOI 10.6084/m9.figshare.3863475.

References

Abdulgader et al. (2015) Abdulgader SM, Shittu AO, Nicol MP, Kaba M. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Africa: a systematic review. Frontiers in Microbiology. 2015;6:348. doi: 10.3389/fmicb.2015.00348. [PMC free article] [PubMed] [Cross Ref]
Aires-de-Sousa et al. (2008) Aires-de-Sousa M, Correia B, de Lencastre H, Multilaboratory Project Collaborators Changing patterns in frequency of recovery of five methicillin-resistant Staphylococcus aureus clones in Portuguese hospitals: surveillance over a 16-year period. Journal of Clinical Microbiology. 2008;46(9):2912–2917. doi: 10.1128/jcm.00692-08. [PMC free article] [PubMed] [Cross Ref]
Amissah et al. (2015) Amissah NA, Chlebowicz MA, Ablordey A, Sabat AJ, Tetteh CS, Prah I, van der Werf TS, Friedrich AW, van Dijl JM, Rossen JW, Stienstra Y. Molecular characterization of Staphylococcus aureus isolates transmitted between patients with buruli ulcer. PLoS Neglected Tropical Diseases. 2015;9(9):e0004049 doi: 10.1371/journal.pntd.0004049. [PMC free article] [PubMed] [Cross Ref]
Baines et al. (2016) Baines SL, Howden BP, Heffernan H, Stinear TP, Carter GP, Seemann T, Kwong JC, Ritchie SR, Williamson DA. Rapid emergence and evolution of Staphylococcus aureus clones harboring fusC-containing staphylococcal cassette chromosome elements. Antimicrobial Agents and Chemotherapy. 2016;60(4):2359–2365. doi: 10.1128/aac.03020-15. [PMC free article] [PubMed] [Cross Ref]
Berendsen et al. (2016) Berendsen EM, Wells-Bennik MHJ, Krawczyk AO, de Jong A, van Heel A, Eijlander RT, Kuipers OP. Draft genome sequences of 10 Bacillus subtilis strains that form spores with high or low heat resistance. Genome Announcements. 2016;4(2):e00124-16 doi: 10.1128/genomea.00124-16. [PMC free article] [PubMed] [Cross Ref]
Blanc et al. (2007) Blanc DS, Petignat C, Wenger A, Kuhn G, Vallet Y, Fracheboud D, Trachsel S, Reymond M, Troillet N, Siegrist HH, Oeuvray S, Bes M, Etienne J, Bille J, Francioli P, Zanetti G. Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus in a small geographic area over an eight-year period. Journal of Clinical Microbiology. 2007;45(11):3729–3736. doi: 10.1128/jcm.00511-07. [PMC free article] [PubMed] [Cross Ref]
Breurec et al. (2011) Breurec S, Zriouil SB, Fall C, Boisier P, Brisse S, Djibo S, Etienne J, Fonkoua MC, Perrier-Gros-Claude JD, Pouillot R, Ramarokoto CE, Randrianirina F, Tall A, Thiberge JM, Laurent F, Garin B. Epidemiology of methicillin-resistant Staphylococcus aureus lineages in five major African towns: emergence and spread of atypical clones. Clinical Microbiology and Infection. 2011;17(2):160–165. doi: 10.1111/j.1469-0691.2010.03219.x. [PubMed] [Cross Ref]
Centers for Disease Control and Prevention (2013) Centers for Disease Control and Prevention . Antibiotic resistance threats in the United States, 2013. Washington, D.C.: U.S. Department of Health and Human Services; 2013.
Chambers (2001) Chambers H. The changing epidemiology of Staphylococcus aureus? Emerging Infectious Diseases. 2001;7(2):178–182. [PMC free article] [PubMed]
Chen & Huang (2014) Chen C-J, Huang Y-C. New epidemiology of Staphylococcus aureus infection in Asia. Clinical Microbiology and Infection. 2014;20(7):605–623. doi: 10.1111/1469-0691.12705. [PubMed] [Cross Ref]
Chua et al. (2014) Chua KYL, Monk IR, Lin Y-H, Seemann T, Tuck KL, Porter JL, Stepnell J, Coombs GW, Davies JK, Stinear TP, Howden BP. Hyperexpression of α-hemolysin explains enhanced virulence of sequence type 93 community-associated methicillin-resistant Staphylococcus aureus. BMC Microbiology. 2014;14(1):31. doi: 10.1186/1471-2180-14-31. [PMC free article] [PubMed] [Cross Ref]
Chua et al. (2011) Chua KYL, Seemann T, Harrison PF, Monagle S, Korman TM, Johnson PDR, Coombs GW, Howden BO, Davies JK, Howden BP, Stinear TP. The dominant Australian community-acquired methicillin-resistant Staphylococcus aureus clone ST93-IV [2B] is highly virulent and genetically distinct. PLoS ONE. 2011;6(10):e25887 doi: 10.1371/journal.pone.0025887. [PMC free article] [PubMed] [Cross Ref]
CLSI (2014) CLSI . Performance Standards for Antimicrobial Susceptibility Testing: Twenty fourth Informational Supplement M100-S24. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2014.
Conceição et al. (2014) Conceição T, Coelho C, Santos-Silva I, de Lencastre H, Aires-de-Sousa M. Epidemiology of methicillin-resistant and -susceptible Staphylococcus aureus in Luanda, Angola: first description of the spread of the MRSA ST5-IVa clone in the African continent. Microbial Drug Resistance. 2014;20(5):441–449. doi: 10.1089/mdr.2014.0007. [PubMed] [Cross Ref]
Coombs et al. (2009) Coombs GW, Nimmo GR, Pearson JC, Christiansen KJ, Bell JM, Collignon PJ, McLaws ML. Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients, 2006. Communicable Diseases Intelligence Quarterly Report. 2009;33(1):10–20. [PubMed]
D’Souza, Rodrigues & Mehta (2010) D’Souza N, Rodrigues C, Mehta A. Molecular characterization of methicillin-resistant Staphylococcus aureus with emergence of epidemic clones of sequence type (ST) 22 and ST 772 in Mumbai, India. Journal of Clinical Microbiology. 2010;48(5):1806–1811. doi: 10.1128/jcm.01867-09. [PMC free article] [PubMed] [Cross Ref]
David & Daum (2010) David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clinical Microbiology Reviews. 2010;23(3):616–687. doi: 10.1128/cmr.00081-09. [PMC free article] [PubMed] [Cross Ref]
de Kraker et al. (2011) de Kraker MEA, Davey PG, Grundmann H, on behalf of the BURDEN study group Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Medicine. 2011;8(10):e1001104 doi: 10.1371/journal.pmed.1001104. [PMC free article] [PubMed] [Cross Ref]
DeLeo et al. (2010) DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet. 2010;375(9725):1557–1568. doi: 10.1016/s0140-6736(09)61999-1. [PMC free article] [PubMed] [Cross Ref]
Denis et al. (2005) Denis O, Deplano A, De Beenhouwer H, Hallin M, Huysmans G, Garrino MG, Glupczynski Y, Malaviolle X, Vergison A, Struelens MJ. Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton–Valentine leucocidin genes in Belgium. Journal of Antimicrobial Chemotherapy. 2005;56(6):1103–1106. doi: 10.1093/jac/dki379. [PubMed] [Cross Ref]
Didelot & Wilson (2015) Didelot X, Wilson DJ. ClonalFrameML: efficient inference of recombination in whole bacterial genomes. PLoS Computational Biology. 2015;11(2):e1004041 doi: 10.1371/journal.pcbi.1004041. [PMC free article] [PubMed] [Cross Ref]
Diekema et al. (2014) Diekema DJ, Richter SS, Heilmann KP, Dohrn CL, Riahi F, Tendolkar S, McDanel JS, Doern GV. Continued emergence of USA300 methicillin-resistant Staphylococcus aureus in the United States: results from a nationwide surveillance study. Infection Control and Hospital Epidemiology. 2014;35(3):285–292. [PubMed]
Egyir et al. (2013) Egyir B, Guardabassi L, Nielsen SS, Larsen J, Addo KK, Newman MJ, Larsen AR. Prevalence of nasal carriage and diversity of Staphylococcus aureus among inpatients and hospital staff at Korle Bu Teaching Hospital, Ghana. Journal of Global Antimicrobial Resistance. 2013;1(4):189–193. [PubMed]
Egyir et al. (2014) Egyir B, Guardabassi L, Sørum M, Nielsen SS, Kolekang A, Frimpong E, Addo KK, Newman MJ, Larsen AR. Molecular epidemiology and antimicrobial susceptibility of clinical Staphylococcus aureus from healthcare institutions in Ghana. PLoS ONE. 2014;9(2):e89716 doi: 10.1371/journal.pone.0089716. [PMC free article] [PubMed] [Cross Ref]
Etienne (2005) Etienne J. Panton-Valentine leukocidin: a marker of severity for Staphylococcus aureus infection? Clinical Infectious Diseases. 2005;41(5):591–593. doi: 10.1086/432481. [PubMed] [Cross Ref]
Fang et al. (2008) Fang H, Hedin G, Li G, Nord CE. Genetic diversity of community-associated methicillin-resistant Staphylococcus aureus in southern Stockholm, 2000–2005. Clinical Microbiology and Infection. 2008;14(4):370–376. doi: 10.1111/j.1469-0691.2007.01941.x. [PubMed] [Cross Ref]
Foster (2005) Foster TJ. Immune evasion by staphylococci. Nature Reviews Microbiology. 2005;3(12):948–958. doi: 10.1038/nrmicro1289. [PubMed] [Cross Ref]
Ghebremedhin et al. (2009) Ghebremedhin B, Olugbosi MO, Raji AM, Layer F, Bakare RA, Konig B, Konig W. Emergence of a community-associated methicillin-resistant Staphylococcus aureus strain with a unique resistance profile in Southwest Nigeria. Journal of Clinical Microbiology. 2009;47(9):2975–2980. doi: 10.1128/jcm.00648-09. [PMC free article] [PubMed] [Cross Ref]
Kim et al. (2007) Kim ES, Song JS, Lee HJ, Choe PG, Park KH, Cho JH, Park WB, Kim S-H, Bang J-H, Kim D-M, Park KU, Shin S, Lee MS, Choi HJ, Kim NJ, Kim E-C, Oh M-D, Kim HB, Choe KW. A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea. Journal of Antimicrobial Chemotherapy. 2007;60(5):1108–1114. doi: 10.1093/jac/dkm309. [PubMed] [Cross Ref]
Kourbatova et al. (2005) Kourbatova EV, Halvosa JS, King MD, Ray SM, White N, Blumberg HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. American Journal of Infection Control. 2005;33(7):385–391. doi: 10.1016/j.ajic.2005.06.006. [PubMed] [Cross Ref]
Kpeli et al. (2016) Kpeli G, Darko Otchere I, Lamelas A, Buultjens AL, Bulach D, Baines SL, Seemann T, Giulieri S, Nakobu Z, Aboagye SY, Owusu-Mireku E, Pluschke G, Stinear TP, Yeboah-Manu D. Possible healthcare-associated transmission as a cause of secondary infection and population structure of Staphylococcus aureus isolates from two wound treatment centres in Ghana. New Microbes and New Infections. 2016;13:92–101. doi: 10.1016/j.nmni.2016.07.001. [PMC free article] [PubMed] [Cross Ref]
Kwong et al. (2016) Kwong JC, Mercoulia K, Tomita T, Easton M, Li HY, Bulach DM, Stinear TP, Seemann T, Howden BP. Prospective whole-genome sequencing enhances national surveillance of Listeria monocytogenes. Journal of Clinical Microbiology. 2016;54(2):333–342. doi: 10.1128/jcm.02344-15. [PMC free article] [PubMed] [Cross Ref]
Maeda et al. (2012) Maeda T, Saga T, Miyazaki T, Kouyama Y, Harada S, Iwata M, Yoshizawa S, Kimura S, Ishii Y, Urita Y, Sugimoto M, Yamaguchi K, Tateda K. Genotyping of skin and soft tissue infection (SSTI)-associated methicillin-resistant Staphylococcus aureus (MRSA) strains among outpatients in a teaching hospital in Japan: application of a phage-open reading frame typing (POT) kit. Journal of Infection and Chemotherapy. 2012;18(6):906–914. doi: 10.1007/s10156-012-0506-4. [PubMed] [Cross Ref]
Monk et al. (2015) Monk IR, Tree JJ, Howden BP, Stinear TP, Foster TJ. Complete bypass of restriction systems for major Staphylococcus aureus lineages. MBio. 2015;6(3):e00308-15 doi: 10.1128/mbio.00308-15. [PMC free article] [PubMed] [Cross Ref]
Nadig et al. (2012) Nadig S, Velusamy N, Lalitha P, Kar S, Sharma S, Arakere G. Staphylococcus aureus eye infections in two Indian hospitals: emergence of ST772 as a major clone. Clinical Ophthalmology. 2012;6:165–173. doi: 10.2147/opth.s23878. [PMC free article] [PubMed] [Cross Ref]
Ngoa et al. (2012) Ngoa UA, Schaumburg F, Adegnika AA, Kösters K, Möller T, Fernandes JF, Alabi A, Issifou S, Becker K, Grobusch MP, Kremsner PG, Lell B. Epidemiology and population structure of Staphylococcus aureus in various population groups from a rural and semi urban area in Gabon, Central Africa. Acta Tropica. 2012;124(1):42–47. doi: 10.1016/j.actatropica.2012.06.005. [PubMed] [Cross Ref]
Oliveira & de Lencastre (2002) Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2002;46(7):2155–2161. doi: 10.1128/aac.46.7.2155-2161.2002. [PMC free article] [PubMed] [Cross Ref]
Otter & French (2010) Otter JA, French GL. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infectious Diseases. 2010;10(4):227–239. doi: 10.1016/s1473-3099(10)70053-0. [PubMed] [Cross Ref]
Page et al. (2015) Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MTG, Fookes M, Keane JA, Parkhill J. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31(22):3691–3. doi: 10.1093/bioinformatics/btv421. [PMC free article] [PubMed] [Cross Ref]
Price, Dehal & Arkin (2010) Price MN, Dehal PS, Arkin AP. FastTree 2–approximately maximum-likelihood trees for large alignments. PLoS ONE. 2010;5(3):e9490 doi: 10.1371/journal.pone.0009490. [PMC free article] [PubMed] [Cross Ref]
Raji et al. (2013) Raji A, Ojemhen O, Umejiburu U, Ogunleye A, Blanc DS, Basset P. High genetic diversity of Staphylococcus aureus in a tertiary care hospital in Southwest Nigeria. Diagnostic Microbiology and Infectious Disease. 2013;77(4):367–369. doi: 10.1016/j.diagmicrobio.2013.08.030. [PubMed] [Cross Ref]
Schaumburg et al. (2014) Schaumburg F, Alabi AS, Peters G, Becker K. New epidemiology of Staphylococcus aureus infection in Africa. Clinical Microbiology and Infection. 2014;20(7):589–596. doi: 10.1111/1469-0691.12690. [PubMed] [Cross Ref]
Schaumburg et al. (2011) Schaumburg F, Ngoa UA, Kösters K, Köck R, Adegnika AA, Kremsner PG, Lell B, Peters G, Mellmann A, Becker K. Virulence factors and genotypes of Staphylococcus aureus from infection and carriage in Gabon. Clinical Microbiology and Infection. 2011;17(10):1507–1513. doi: 10.1111/j.1469-0691.2011.03534.x. [PubMed] [Cross Ref]
Seybold et al. (2006) Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, Ray SM, Blumberg HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care—associated blood stream infections. Clinical Infectious Diseases. 2006;42(5):647–656. doi: 10.1086/499815. [PubMed] [Cross Ref]
Shambat et al. (2012) Shambat S, Nadig S, Prabhakara S, Bes M, Etienne J, Arakere G. Clonal complexes and virulence factors of Staphylococcus aureus from several cities in India. BMC Microbiology. 2012;12(1):64. doi: 10.1186/1471-2180-12-64. [PMC free article] [PubMed] [Cross Ref]
Shittu et al. (2012) Shittu A, Oyedara O, Abegunrin F, Okon K, Raji A, Taiwo S, Ogunsola F, Onyedibe K, Elisha G. Characterization of methicillin-susceptible and -resistant staphylococci in the clinical setting: a multicentre study in Nigeria. BMC Infectious Diseases. 2012;12(1):286. doi: 10.1186/1471-2334-12-286. [PMC free article] [PubMed] [Cross Ref]
Voyich et al. (2005) Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Said-Salim B, Porcella SF, Long RD, Dorward DW, Gardner DJ, Kreiswirth BN, Musser JM, DeLeo FR. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. Journal of Immunology. 2005;175(6):3907–3919. doi: 10.4049/jimmunol.175.6.3907. [PubMed] [Cross Ref]
Williamson, Coombs & Nimmo (2014) Williamson DA, Coombs GW, Nimmo GR. Staphylococcus aureus ‘Down Under’: contemporary epidemiology of S. aureus in Australia, New Zealand, and the South West Pacific. Clinical Microbiology and Infection. 2014;20(7):597–604. doi: 10.1111/1469-0691.12702. [PubMed] [Cross Ref]
Witte et al. (1997) Witte W, Kresken M, Braulke C, Cuny C. Increasing incidence and widespread dissemination of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals in central Europe, with special reference to German hospitals. Clinical Microbiology and Infection. 1997;3(4):414–422. doi: 10.1111/j.1469-0691.1997.tb00277.x. [PubMed] [Cross Ref]
Yu et al. (2008) Yu F, Chen Z, Liu C, Zhang X, Lin X, Chi S, Zhou T, Chen Z, Chen X. Prevalence of Staphylococcus aureus carrying Panton–Valentine leukocidin genes among isolates from hospitalised patients in China. Clinical Microbiology and Infection. 2008;14(4):381–384. doi: 10.1111/j.1469-0691.2007.01927.x. [PubMed] [Cross Ref]

Articles from PeerJ are provided here courtesy of PeerJ, Inc